Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Bladder Cancer

Free Subscription 08.07.2024 3 Acta Clin Croat 1 Aging (Albany NY) 2 Asian J Endosc Surg 1 Biochem Genet 1 Biomed J 1 BJU Int 1 BMC Microbiol 1 Can Vet J 2 Cancer 2 Cancer Genomics Proteomics 1 Cancer Radiother 1 Cell Mol Biol Lett 1 Clin Genitourin Cancer 2 Comb Chem High Throughput Screen 1 Endoscopy 1 Expert Opin Drug Saf 1 Future Oncol 6 Hinyokika Kiyo 1 Int Cancer Conf J 1 Int Immunopharmacol 2 Int J Cancer 1 Int J Pharm 3 Int J Urol 1 Int Neurourol J 1 J Clin Invest 1 J Clin Oncol 1 J Pak Med Assoc 2 J Robot Surg 1 J Transl Med 1 J Urol 1 Life Sci 1 Medicine (Baltimore) 1 Minerva Urol Nephrol 1 Mol Ther Oncol 1 Nat Med 1 Nat Prod Res 3 Nat Rev Urol 1 Oncologist 1 Oncology 1 Sci Rep

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Clin Croat

1. GLAVCIC M, Cudina I, Hrabac P, Glavcic G, et al
   UROTHELIAL CARCINOMA BEFORE AND DURING THE COVID-19 PANDEMIC IN CROATIA - A SINGLE-CENTER STUDY.
   Acta Clin Croat. 2023;62.
   PubMed         Abstract available
   
   
2. VIDOSAVLJEVIC M, Puntaric D, Gvozdic V, Vidosavljevic D, et al
   ARSENIC IN DRINKING WATER AND URINE AND ITS RELATIONSHIP WITH MALIGNANT TUMORS OF URINARY TRACT IN OSIJEK-BARANJA COUNTY, CROATIA.
   Acta Clin Croat. 2023;62.
   PubMed         Abstract available
   
   
3. CIKIC B, Zekulic T, Penezic L, Andelic J, et al
   OPEN RADICAL CYSTECTOMY: SINGLE CENTER RESULTS AND OUTCOMES IN THE LAST FIVE YEARS.
   Acta Clin Croat. 2023;62.
   PubMed         Abstract available
   
   

   
   Aging (Albany NY)

4. XU J, Chen R, Yang Y, Xu S, et al
   Genetically predicted 91 circulating inflammatory proteins in relation to risk of urological malignancies: a Mendelian randomization study.
   Aging (Albany NY). 2024;16:10366-10379.
   PubMed         Abstract available
   
   

   
   Asian J Endosc Surg

5. WATANABE S, Kobayashi H, Hiroe N, Iwasawa T, et al
   Robot-assisted radical cystectomy for bladder cancer after low anterior resection: A case report.
   Asian J Endosc Surg. 2024;17:e13345.
   PubMed         Abstract available
   
   
6. NARA T, Numakura K, Furihata K, Kikuchi A, et al
   Arterio-ureteral fistula from a pseudoaneurysm of the right common iliac artery after robot-assisted laparoscopic radical cystectomy: A case report.
   Asian J Endosc Surg. 2024;17:e13348.
   PubMed         Abstract available
   
   

   
   Biochem Genet

7. LE M, Qing M, Zeng X, Cheng S, et al
   m6A-YTHDF1 Mediated Regulation of GRIN2D in Bladder Cancer Progression and Aerobic Glycolysis.
   Biochem Genet. 2024 Jun 29. doi: 10.1007/s10528-024-10875.
   PubMed         Abstract available
   
   

   
   Biomed J

8. CHEN ST, Chang KS, Lin WY, Hsu SY, et al
   Activating transcription factor 3 is an antitumor gene synergizing with growth differentiation factor 15 to modulate cell growth in human bladder cancer.
   Biomed J. 2024 Jun 26:100756. doi: 10.1016/j.bj.2024.100756.
   PubMed         Abstract available
   
   

   
   BJU Int

9. ANTONELLI L, Wendel-Garcia PD, Deforth M, Afferi L, et al
   Thromboprophylaxis during neoadjuvant chemotherapy for bladder cancer reduces thromboembolism and bleeding.
   BJU Int. 2024 Jul 3. doi: 10.1111/bju.16444.
   PubMed         Abstract available
   
   

   
   BMC Microbiol

10. WANG B, Qiu Y, Xie M, Huang P, et al
    Gut microbiota Parabacteroides distasonis enchances the efficacy of immunotherapy for bladder cancer by activating anti-tumor immune responses.
    BMC Microbiol. 2024;24:237.
    PubMed         Abstract available
    
    

    
    Can Vet J

11. PARK J, Lee SG, Jeong SM, Nam A, et al
    Inflammatory myofibroblastic tumor in the urinary bladder in a dog.
    Can Vet J. 2024;65:643-648.
    PubMed         Abstract available
    
    

    
    Cancer

12. MARTINI DJ, Case KB, Gratz D, Pellegrini K, et al
    PD-L1 and nectin-4 expression and genomic characterization of bladder cancer with divergent differentiation.
    Cancer. 2024 Jul 3. doi: 10.1002/cncr.35465.
    PubMed         Abstract available
    
    
13. NIERENGARTEN MB
    New standard of care for bladder cancer.
    Cancer. 2024;130:2407.
    PubMed        
    
    

    
    Cancer Genomics Proteomics

14. NAGATA Y, Quynh NT, Aono H, Harada K, et al
    Melatonin Inhibits Chemical Carcinogen-mediated Malignant Transformation of Urothelial Cells: In Vitro Evidence.
    Cancer Genomics Proteomics. 2024;21:388-394.
    PubMed         Abstract available
    
    
15. SHABBIR R, Telfer BA, Dickie B, Reardon M, et al
    Implementation of Oxygen Enhanced Magnetic Resonance Imaging (OE-MRI) and a Pilot Genomic Study of Hypoxia in Bladder Cancer Xenografts.
    Cancer Genomics Proteomics. 2024;21:380-387.
    PubMed         Abstract available
    
    

    
    Cancer Radiother

16. BOUE-RAFLE A, Briens A, Supiot S, Blanchard P, et al
    [Does radiation therapy for prostate cancer increase the risk of second cancers?].
    Cancer Radiother. 2024;28:293-307.
    PubMed         Abstract available
    
    

    
    Cell Mol Biol Lett

17. LIU J, Wang X, Jiang W, Azoitei A, et al
    Impairment of alpha-tubulin and F-actin interactions of GJB3 induces aneuploidy in urothelial cells and promotes bladder cancer cell invasion.
    Cell Mol Biol Lett. 2024;29:94.
    PubMed         Abstract available
    
    

    
    Clin Genitourin Cancer

18. VINICIUS SUARTZ C, Araujo Simoes PA, Doratioto Serrano Faria Braz N, da Silva FR, et al
    Surviving the Storm: Challenges of Bladder Cancer Care During the COVID-19 Pandemic.
    Clin Genitourin Cancer. 2024;22:102129.
    PubMed         Abstract available
    
    

    
    Comb Chem High Throughput Screen

19. LI C, Chu G, Ma G, Chen X, et al
    SLC16A3 is a Prognostic Marker and Affects Immune Regulation in Bladder Cancer.
    Comb Chem High Throughput Screen. 2024.
    PubMed         Abstract available
    
    
20. JIANG D, Zhang H, Yin B, He M, et al
    The Prognostic Hub Gene POLE2 Promotes BLCA Cell Growth via the PI3K/AKT Signaling Pathway.
    Comb Chem High Throughput Screen. 2024;27:1984-1998.
    PubMed         Abstract available
    
    

    
    Endoscopy

21. ALWALI A, Schafmayer C, Kamaleddine I
    Combined endoscopic management of a postoperative rectocutaneous fistula after cystectomy using modified percutaneous endofistular and transanal endoluminal vacuum therapy.
    Endoscopy. 2024;56.
    PubMed        
    
    

    
    Expert Opin Drug Saf

22. PENG Y, Song Y, Du Y, Qin C, et al
    Comparative analysis of adverse events among intravesical drugs in bladder cancer: a real-world study on FAERS database.
    Expert Opin Drug Saf. 2024 Jul 4:1-8. doi: 10.1080/14740338.2024.2374921.
    PubMed         Abstract available
    
    

    
    Future Oncol

23. CHAMIE K, Chang SS, Rosser CJ, Kramolowski E, et al
    N-803 Plus BCG Treatment for BCG-Naive or -Unresponsive Non-Muscle Invasive Bladder Cancer: A Plain Language Review.
    Future Oncol. 2024 Jul 2:1-11. doi: 10.1080/14796694.2024.2363744.
    PubMed         Abstract available
    
    

    
    Hinyokika Kiyo

24. NAGAHAMA K, Ito M, Imai K, Masuda N, et al
    [Repair of Vaginal Cuff Dehiscence after Laparoscopic Radical Cystectomy with Gracilis Myocutaneous Flap].
    Hinyokika Kiyo. 2024;70:155-159.
    PubMed         Abstract available
    
    
25. AKAI T, Ueno S, Takeda A, Tokuyama S, et al
    [A Case of Lymphorrhea after Radical Cystectomy Treated by Ultrasound-Guided Inguinal Intranodal Lymphangiography].
    Hinyokika Kiyo. 2024;70:123-127.
    PubMed         Abstract available
    
    
26. YAMASAKI T, Yoshino T, Kojo K, Kimura T, et al
    [Two Cases of Bleeding from the Ileal Conduit Due to Ectopic Varices].
    Hinyokika Kiyo. 2024;70:101-106.
    PubMed         Abstract available
    
    
27. AIGASE T, Tatenuma T, Uemura K, Makiyama K, et al
    [A Case of Successful Treatment of Small Cell Carcinoma of the Bladder with Pembrolizumab].
    Hinyokika Kiyo. 2024;70:93-99.
    PubMed         Abstract available
    
    
28. KIYAMA Y, Sekii Y, Inoguchi S, Matsumura S, et al
    [A Case of Primary Adenocarcinoma Mucinous Subtype of the Bladder].
    Hinyokika Kiyo. 2024;70:89-92.
    PubMed         Abstract available
    
    
29. MOROOKA D, Nakajima Y, Tabata H, Hotta H, et al
    [A Case of Systemic Wild-Type Transthyretin Amyloid (ATTR) Amyloidosis Diagnosed in a Patient with Gross Hematuria].
    Hinyokika Kiyo. 2024;70:65-69.
    PubMed         Abstract available
    
    

    
    Int Cancer Conf J

30. TORII S, Narita T, Homma T, Kinoshita T, et al
    Successful pre-surgical treatment with carboplatin and gemcitabine chemotherapy for a patient with muscle-invasive bladder cancer and severe renal dysfunction.
    Int Cancer Conf J. 2024;13:230-234.
    PubMed         Abstract available
    
    

    
    Int Immunopharmacol

31. JIAN Y, Chen Q, Al-Danakh A, Xu Z, et al
    Identification and validation of sialyltransferase ST3Gal5 in bladder cancer through bioinformatics and experimental analysis.
    Int Immunopharmacol. 2024;138:112569.
    PubMed         Abstract available
    
    

    
    Int J Cancer

32. DI BELLO F, Siech C, Jannello LMI, de Angelis M, et al
    Contemporary survival in metastatic bladder cancer patients: A population-based study.
    Int J Cancer. 2024 Jul 3. doi: 10.1002/ijc.35077.
    PubMed         Abstract available
    
    
33. NESIC M, Rasmussen MH, Henriksen TV, Demuth C, et al
    Beyond basics: Key mutation selection features for successful tumor-informed ctDNA detection.
    Int J Cancer. 2024;155:925-933.
    PubMed         Abstract available
    
    

    
    Int J Pharm

34. PEREIRA SANTOS CARVALHO I, Bueno Silva L, Luis Ferraz do Amaral R, Nader Chrysostomo-Massaro T, et al
    Evaluation of in vivo and in vitro efficacy of solasonine/solamargine-loaded lipid-polymer hybrid nanoparticles against bladder cancer.
    Int J Pharm. 2024 Jul 1:124411. doi: 10.1016/j.ijpharm.2024.124411.
    PubMed         Abstract available
    
    

    
    Int J Urol

35. ASAKAWA K, Waratani M, Massey O, Holbrook T, et al
    Real-world epidemiology and treatment patterns of patients with locally advanced or metastatic urothelial carcinoma: Retrospective analysis of Diagnosis Procedure Combination claims data in Japan.
    Int J Urol. 2024;31:730-738.
    PubMed         Abstract available
    
    
36. HATTORI Y, Fujiwara T, Hagimoto H, Kokubun H, et al
    Efficacy and safety of dose-dense gemcitabine plus cisplatin as neoadjuvant chemotherapy for muscle-invasive bladder cancer.
    Int J Urol. 2024 Jul 3. doi: 10.1111/iju.15524.
    PubMed         Abstract available
    
    
37. YASUDA Y, Numao N, Fujiwara R, Takemura K, et al
    Surgical outcomes and predictive value for major complications of robot-assisted radical cystectomy of real-world data in a single institution in Japan.
    Int J Urol. 2024;31:724-729.
    PubMed         Abstract available
    
    

    
    Int Neurourol J

38. SEOK J, Kwak Y, Kim S, Kim EM, et al
    Advances in Liquid Biopsy for Diagnosis of Bladder Cancer.
    Int Neurourol J. 2024;28:83-95.
    PubMed         Abstract available
    
    

    
    J Clin Invest

39. LI W, Chen C, Zheng H, Lin Y, et al
    UBE2C-induced crosstalk between mono- and polyubiquitination of SNAT2 promotes lymphatic metastasis in bladder cancer.
    J Clin Invest. 2024;134:e179122.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

40. KLUMPER N, Tran NK, Zschabitz S, Hahn O, et al
    NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer.
    J Clin Oncol. 2024;42:2446-2455.
    PubMed         Abstract available
    
    

    
    J Pak Med Assoc

41. SAEED S, Khan D, Faisal S, Rauf F, et al
    A histopathological and epidemiological study of urothelial carcinoma at a tertiary care centre in Peshawar, Pakistan.
    J Pak Med Assoc. 2024;74:1160-1162.
    PubMed         Abstract available
    
    

    
    J Robot Surg

42. FUKATA S, Kawaguchi A, Yoshimura R, Fukuhara H, et al
    Investigation of risk factors for vaginal dehiscence and development of small bowel evisceration after robot-assisted radical cystectomy for female bladder cancer and an improved vaginal reconstruction technique to prevent its onset.
    J Robot Surg. 2024;18:276.
    PubMed         Abstract available
    
    
43. CELLA L, Basile G, Moretto S, Paciotti M, et al
    Robotic assisted vs open radical cystectomy: an updated systematic review and meta-analysis.
    J Robot Surg. 2024;18:277.
    PubMed         Abstract available
    
    

    
    J Transl Med

44. YANG Z, Chen Q, Dong S, Xu P, et al
    Hypermethylated TAGMe as a universal-cancer-only methylation marker and its application in diagnosis and recurrence monitoring of urothelial carcinoma.
    J Transl Med. 2024;22:608.
    PubMed         Abstract available
    
    

    
    J Urol

45. DINNEY CPN, Narayan VM
    Reply: Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guerin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial.
    J Urol. 2024 Jul 5:101097JU0000000000004128. doi: 10.1097/JU.0000000000004128.
    PubMed        
    
    

    
    Life Sci

46. CHEN H, Cai Z, Dong X, Chen W, et al
    Cigarette smoking-related OLC1 overexpression associated with poor prognosis in bladder urothelial carcinoma.
    Life Sci. 2024;351:122821.
    PubMed         Abstract available
    
    

    
    Medicine (Baltimore)

47. YANG X, Zhang Y, Liu J, Feng Y, et al
    Construction and validation of a prognostic model for bladder cancer based on disulfidptosis-related lncRNAs.
    Medicine (Baltimore). 2024;103:e38750.
    PubMed         Abstract available
    
    

    
    Minerva Urol Nephrol

48. PETRELLA G, Ciufolini G, Lentini S, Montorsi F, et al
    The grade of systemic inflammation, immune inhibition, and gut dysbiosis as prognostic factors for bladder cancer recurrence: a metabolomics approach.
    Minerva Urol Nephrol. 2024 Jul 1. doi: 10.23736/S2724-6051.24.05747.
    PubMed         Abstract available
    
    

    
    Mol Ther Oncol

49. PAPADIMITRIOU MA, Pilala KM, Panoutsopoulou K, Levis P, et al
    CDKN2A copy number alteration in bladder cancer: Integrative analysis in patient-derived xenografts and cancer patients.
    Mol Ther Oncol. 2024;32:200818.
    PubMed         Abstract available
    
    

    
    Nat Med

50. LI R, Shah PH, Stewart TF, Nam JK, et al
    Publisher Correction: Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial.
    Nat Med. 2024 Jul 2. doi: 10.1038/s41591-024-03157.
    PubMed        
    
    

    
    Nat Prod Res

51. HOSSEINI SA
    The therapeutic effect of baicalin in the treatment of bladder cancer: a mini-review.
    Nat Prod Res. 2024 Jul 2:1-5. doi: 10.1080/14786419.2024.2373955.
    PubMed         Abstract available
    
    

    
    Nat Rev Urol

52. SANTONI M, Takeshita H, Massari F, Bamias A, et al
    Pembrolizumab plus enfortumab vedotin in urothelial cancer.
    Nat Rev Urol. 2024;21:387-388.
    PubMed        
    
    
53. LLOYD L
    The bladder tumour microbiome and BCG response.
    Nat Rev Urol. 2024;21:389.
    PubMed        
    
    
54. SMITH DJ, Lunj S, Adamson AD, Nagarajan S, et al
    CRISPR-Cas9 potential for identifying novel therapeutic targets in muscle-invasive bladder cancer.
    Nat Rev Urol. 2024 Jul 1. doi: 10.1038/s41585-024-00901.
    PubMed         Abstract available
    
    

    
    Oncologist

55. PICHLER R, Fritz J, Mari A, Cadenar A, et al
    Cisplatin eligibility in the neoadjuvant setting of patients with muscle-invasive bladder cancer undergoing radical cystectomy.
    Oncologist. 2024 Jul 2:oyae160. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Oncology

56. NAKAMURA K, Ohno T, Inamoto T, Takai T, et al
    Pattern of Expression of MicroRNA in Patients with Radiation-Induced Bladder Injury.
    Oncology. 2024;102:585-592.
    PubMed         Abstract available
    
    

    
    Sci Rep

57. SAIZONOU I, Lascombe I, Monnien F, Bedgedjian I, et al
    Concomitant decrease of E- and A-FABP expression predicts worse survival in urothelial bladder cancer patients.
    Sci Rep. 2024;14:15390.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.